Guatemala Pharmaceuticals & Healthcare Q2 2018
Guatemala’s pharmaceutical spending will post high growth rates over the next ten years on the back of economicdevelopment. The increasing burden of chronic diseases will ensure that demand for medical treatment remains on the rise. Morebroadly, the relatively large and growing population will drive commercial opportunities for drugmakers and healthcare suppliers.However, low per capita spending on medicine and a poor operating environment will limit growth opportunities while skewing themarket towards the use of generic drugs. As the market develops, improved opportunities for investment in operations as well as inlocal drug manufacturing will slowly improve.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook